167 related articles for article (PubMed ID: 35609325)
1. BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells.
Wang L; Ji X; Mao C; Yu R
Bioengineered; 2022 May; 13(5):12888-12898. PubMed ID: 35609325
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
4. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis.
Zhao W; Yu D; Chen Z; Yao W; Yang J; Ramalingam SS; Sun SY
Cancer Lett; 2021 Oct; 519():141-149. PubMed ID: 34245854
[TBL] [Abstract][Full Text] [Related]
6. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
[TBL] [Abstract][Full Text] [Related]
8. YAP promotes myogenic differentiation
Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic signaling of MEK5-ERK5.
Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
[TBL] [Abstract][Full Text] [Related]
10. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
Raviv Z; Kalie E; Seger R
J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
[TBL] [Abstract][Full Text] [Related]
11. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.
Nakamura K; Uhlik MT; Johnson NL; Hahn KM; Johnson GL
Mol Cell Biol; 2006 Mar; 26(6):2065-79. PubMed ID: 16507987
[TBL] [Abstract][Full Text] [Related]
12. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
Sohn SJ; Lewis GM; Winoto A
EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
[TBL] [Abstract][Full Text] [Related]
14. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
Diéguez-Martínez N; Espinosa-Gil S; Yoldi G; Megías-Roda E; Bolinaga-Ayala I; Viñas-Casas M; Gorgisen G; Domingo-Ortí I; Pérez-Montoyo H; Bayascas JR; Colas E; Dolcet X; Lizcano JM
Cell Mol Life Sci; 2022 Sep; 79(10):524. PubMed ID: 36123565
[TBL] [Abstract][Full Text] [Related]
15. ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation.
Wang YS; Zhou J; Liang C; Hong K; Cheng XS; Wu ZG
Environ Toxicol Pharmacol; 2013 Sep; 36(2):724-731. PubMed ID: 23896225
[TBL] [Abstract][Full Text] [Related]
16. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.
Clark PR; Jensen TJ; Kluger MS; Morelock M; Hanidu A; Qi Z; Tatake RJ; Pober JS
Microcirculation; 2011 Feb; 18(2):102-17. PubMed ID: 21166929
[TBL] [Abstract][Full Text] [Related]
17. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
[TBL] [Abstract][Full Text] [Related]
18. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway.
Lee KS; Park JH; Lim HJ; Park HY
Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855
[TBL] [Abstract][Full Text] [Related]
19. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy.
Luan Q; Jin L; Jiang CC; Tay KH; Lai F; Liu XY; Liu YL; Guo ST; Li CY; Yan XG; Tseng HY; Zhang XD
Autophagy; 2015; 11(7):975-94. PubMed ID: 26018731
[TBL] [Abstract][Full Text] [Related]
20. CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL.
Gilley R; Lochhead PA; Balmanno K; Oxley D; Clark J; Cook SJ
Cell Signal; 2012 Jan; 24(1):170-80. PubMed ID: 21924351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
